A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer. [electronic resource]
Producer: 20110602Description: 1569-75 p. digitalISSN:- 1525-1438
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Disease Progression
- Female
- Humans
- Irinotecan
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Survival Analysis
- Treatment Outcome
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.